Abstract
Abstract A new mouse model of ATRX-deficient pediatric glioblastoma reveals a DNA repair defect that renders the tumors more sensitive to DNA-damaging agents.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have